Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know
07:33pm, Monday, 23'rd Oct 2023
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $367.66, denoting a +1.6% change from the preceding trading day.
GILD or VRTX: Which Is the Better Value Stock Right Now?
12:47pm, Thursday, 19'th Oct 2023
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX). But which of these two companies is the best option
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
10:33am, Thursday, 19'th Oct 2023
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
4 Ways to Grow $100,000 Into $1 Million for Retirement
09:13am, Thursday, 19'th Oct 2023
Realty Income's total returns deliver. Alphabet is still turning investors into millionaires.
5 Biotech Stocks Set to Outpace Q3 Earnings Estimates
12:47pm, Wednesday, 18'th Oct 2023
Let us look at some biotech stocks, AMGN, BIIB, GSK, PRTA and VRTX, which are poised to beat on third-quarter earnings.
Why Vertex (VRTX) is Poised to Beat Earnings Estimates Again
01:31pm, Tuesday, 17'th Oct 2023
Vertex (VRTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Vertex Pharmaceuticals (VRTX) Increases Yet Falls Behind Market: What Investors Need to Know
07:33pm, Monday, 16'th Oct 2023
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $374, denoting a +0.81% change from the preceding trading day.
2 Healthcare Stocks Near 52-Week Highs Still Worth Buying
09:26am, Monday, 16'th Oct 2023
Healthcare stocks, on balance, haven't been great investments in 2023. Regeneron Pharmaceuticals and Vertex Pharmaceuticals have been two glaring exceptions to this trend.
This Cathie Wood Stock Is Set to Soar 100%, Says Wall Street
05:30am, Monday, 16'th Oct 2023
Superstar investor Wood looks for innovators whose products could be game changers down the road. She goes for companies that are undervalued today considering their long-term potential.
Is Vertex Pharmaceuticals Stock a Buy Now?
06:18am, Sunday, 15'th Oct 2023
Vertex's sales have been slowing down, and this year the top line may rise by less than 10%. The company has multiple assets in phase 3 trials, which could unlock more growth potential for the busines
The Surprising $5 Billion Opportunity That Drove Vertex Pharmaceuticals Stock To A Record High
03:17pm, Thursday, 12'th Oct 2023
Almost three-quarters of prescribed pain meds are opioids, and Vertex could change that. VRTX stock broke out to a record high Thursday.
BEAM Focuses on Developing Gene Drug for Growth
11:16am, Tuesday, 10'th Oct 2023
While BEAM's pipeline candidates are in early-stage clinical studies, their development is progressing well. Collaborations are a primary source of revenues in the absence of a marketed product.
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
07:33pm, Monday, 09'th Oct 2023
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $355.20, indicating a -1.5% shift from the previous trading day.
Cramer's Mad Dash: Vertex Pharmaceuticals
10:58am, Monday, 09'th Oct 2023
CNBC's Jim Cramer delivers his daily Mad Dash.
Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'
10:18am, Monday, 09'th Oct 2023
CNBC's Jim Cramer said investors keep an eye on Vertex Pharmaceuticals (VRTX) as the company develops a non-opioid pain drug.
